| Financial Year |
March 31 2023 |
| Monetary Funds |
516,461,092.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
138,311,184.51 |
| Advances to Suppliers |
16,046,165.32 |
| Other Receivables |
2,669,745.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
268,958,720.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,294,112.86 |
| Total Current Assets |
1,414,081,176.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,329,624,158.66 |
| Under-construction Projects |
1,353,549.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
125,785,435.05 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,551,273.96 |
| Deferred Income Tax Assets |
3,899,534.04 |
| Other Non-Current Assets |
39,124,348.18 |
| Sub-Total of Non-Current Assets |
3,506,338,299.79 |
| Total Assets |
4,920,419,476.19 |
| Short-Term Loans |
228,780,943.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
36,745,217.31 |
| Accounts Payable |
285,350,230.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,462,114.80 |
| Taxes Payable |
8,542,755.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,431,450.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
243,907,943.91 |
| Other Current Liabilities |
3,924,420.27 |
| Sub-Total of Current Liabilities |
935,830,665.04 |
| Long-term Loans |
380,367,133.31 |
| Bonds Payable |
518,723,969.66 |
| Long-Term Accounts Payable |
52,069,022.19 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
33,824,385.85 |
| Other Non-Current Liabilities |
54,746,625.06 |
| Sub-Total of Non-Current Liabilities |
1,055,713,737.22 |
| Total Liabilities |
1,991,544,402.26 |
| Paid-In Capital(Or Share Stock) |
600,005,625.00 |
| Capital Surplus |
586,047,850.16 |
| Surplus Reserve |
132,879,553.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,502,916,667.54 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,928,875,073.93 |
| Owner's Equity（Stockholder's Equity） |
2,928,875,073.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,920,419,476.19 |
